1[1]Bertrand P, Girard N, Duval C, et al. Increased hyaluronidase levels in breast tumor metastases. Int J Cancer, 1997, 73: 327-331.
2[2]Lokeshwar VB, Lokeshwar BL, Pham HT, et al. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res, 1996,56:651-657.
3[3]Tamakoshi K, Kikkawa F, Maeda O, et al. Hyaluronidese activity in gynaecological cancer tissues with different matastatic forms. Br J Cancer, 1997,75:1807-1811.
4[4]Kim J, Yu W, Kovalski K, et al. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell, 1998,94:353-362.
5[5]Liu D, Pearlman E, Diaconu E, et al. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci USA, 1996, 3:7832-7837.
6[6]Lin Y, Kimmel LH, Myles DG, et al. Molecular cloning of the human and monkey sperm surface protein PH-20. Proc Natl Acad Sci USA, 1993, 90:10071-10075.
7[7]Csoka TB, Frost GI, Stern R. Hyaluronidases in tissue invasion.Inavsion Metastasis, 1997, 17: 297-311.
8Lokeshwar VB, Rubinowicz D, Schroeder GL, et al. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1hyaluronidase in prostate cancer. J Biol Chem, 2001, 276:11922-11932.
9Novak U, Stylli SS, Kaye AH, et al. Hyaluronidase-2 overexpression accelerates intracerebral but not subcutaneous tumor formation of murine astrocytoma cells. Cancer Res, 1999, 59:6246-6250.
10Lokeshwar VB, Lokeshwar BL, Pham HT, et al. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression. Cancer Res, 1996, 56:651-657.
